CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024
admin@pathologynews.com2024-12-06T13:35:35+00:00CB Insights named Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, to its 2024 Digital Health 50 list of the world’s most innovative private digital health companies. Proscia is also ranked as the top vendor in CB Insights’ ‘Digital pathology – general diagnostics’ and ‘Digital pathology – oncology diagnostics’ Execution, Strength, and Positioning (ESP) market matrices.










